| 000 | 01485 a2200361 4500 | ||
|---|---|---|---|
| 005 | 20250515071340.0 | ||
| 264 | 0 | _c20070906 | |
| 008 | 200709s 0 0 eng d | ||
| 022 | _a1246-7820 | ||
| 024 | 7 |
_a10.1016/j.tracli.2007.04.008 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFlan, Benoît | |
| 245 | 0 | 0 |
_aManufacture of plasma-derived products in France and measures to prevent the risk of vCJD transmission: precautionary measures and efficacy of manufacturing processes in prion removal. _h[electronic resource] |
| 260 |
_bTransfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine _cMay 2007 |
||
| 300 |
_a51-62 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aBlood Component Transfusion _xadverse effects |
| 650 | 0 | 4 |
_aBlood Transfusion _xstandards |
| 650 | 0 | 4 | _aChromatography |
| 650 | 0 | 4 |
_aCreutzfeldt-Jakob Syndrome _xtransmission |
| 650 | 0 | 4 | _aEthanol |
| 650 | 0 | 4 | _aFrance |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aPrion Diseases _xtransmission |
| 650 | 0 | 4 |
_aPrions _xisolation & purification |
| 650 | 0 | 4 | _aRisk Assessment |
| 650 | 0 | 4 | _aSafety |
| 650 | 0 | 4 | _aTransfusion Reaction |
| 650 | 0 | 4 | _aUltrafiltration |
| 700 | 1 | _aArrabal, Samuel | |
| 773 | 0 |
_tTransfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine _gvol. 14 _gno. 1 _gp. 51-62 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.tracli.2007.04.008 _zAvailable from publisher's website |
| 999 |
_c17080359 _d17080359 |
||